THC Cross-Tolerance to Anandamide-Like Compounds Varied Across Four Mouse Tests

Prior THC dosing did not reduce every response to anandamide-like compounds in mice. Cross-tolerance appeared for some compounds and behavioral measures, while hypothermic responses showed no cross-tolerance in the experiment.

Four endpoints provided different answers

Researchers examined spontaneous activity, a tail-flick pain response, rectal temperature and ring immobility associated with catalepsy. Repeated THC produced pronounced tolerance to THC's own effects across these measures. The comparison compounds were anandamide, 2-methylanandamide and O-1812.

The pattern depended on the compound

All three anandamide-like compounds showed cross-tolerance on the antinociceptive measure. Suppression of spontaneous activity showed cross-tolerance for 2-methylanandamide and O-1812, while catalepsy showed it for O-1812. None showed cross-tolerance for hypothermia. Where cross-tolerance appeared, its magnitude was smaller than the tolerance to THC described in the abstract.

Shared receptor pharmacology was not the whole answer

The authors suggested only partial overlap between anandamide-like compounds and traditional cannabinoids. They proposed regional receptor adaptation and endocannabinoid release as possible contributors, rather than demonstrating a single settled mechanism. These are experimental compounds and injected exposures, not interchangeable forms of consumer cannabis.

The study illustrates how the question 'Is there cross-tolerance?' can be incomplete. A useful answer identifies the prior exposure, challenge compound and measured function. Preserved temperature effects alongside reduced pain-response effects also prevent a global claim that prior THC made the animals insensitive to cannabinoids.

Related: interpreting cannabis tolerance claims.

Research cited

Wiley JL; Smith FL; Razdan RK; Dewey WL. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. European journal of pharmacology (2005). doi:10.1016/j.ejphar.2005.01.006. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us